Maja Cikes
@MajaCikes
Followers
829
Following
1K
Statuses
632
Heart Failure & Echo Cardiologist, University of Zagreb School of Medicine, Croatia
Zagreb
Joined April 2018
Delighted to share our recent work from the #PCHF_VAD registry published in the Eur J Heart Fail depicting the evolving landscape of #LVAD recipients in Europe, with ⬆️ survival and ⬇️ adverse events in the most recent implantation era! Kudos @NinaJakus ⭐️
2
9
49
RT @CircHF: Featured Science Sim Pub with #AHA24 from @PabloMikiMarti & @scottdsolomon et al published in @CircHF: Natural Language Proces…
0
1
0
RT @PabloMikiMarti: Adjudicating #HeartFailure in global trials is slow & costly. At #AHA24, we presented HF-NLP, an #AI model using #NLP t…
0
4
0
RT @hmkyale: 1/ New insights on blood pressure in HFmrEF/HFpEF! 🩺 A pooled analysis of 16,900+ patients shows a J-shaped relationship betwe…
0
8
0
RT @SJGreene_md: Terrific work led by @JoshJPharmD from @AHAScience #GWTG_HF. 🔥#SimPub with #AHA24 now in @CircHF Social Determinants of…
0
5
0
RT @JCardFail: ICYMI: Catch up on @HFSA Scientific Statement on Cardio-Oncology & HF in #JCF! 🔥 From HF in patients with cancer ➡️ cancer…
0
9
0
RT @TorBiering: Our latest NUDGE trial just published in @JAMA_current 👇 Led by the brilliant @niklasdj1, in collaboration with amazing co…
0
10
0
RT @MasriAhmadMD: Excellent paper in @JACCJournals on screening yield in #HCM Important and useful data for physicians and patients htt…
0
17
0
RT @CardioZurich: Meet the Legends🎖️McDonagh, Pfeffer & Swedberg as they empower current #HeartFailure practice & future experts at #PCHF Z…
0
7
0
RT @JeffTeuteberg: Yikes‼️ Don't stop the GDMT💊 pre d/c that patients were taking on admission🚨 Sobering data from @JACCJournals & @Stanfo…
0
24
0
RT @TheJHLT: When used upfront, use of Impella 5.0/5.5 for cardiogenic shock is associated with 67% survival and high rates of bridge to he…
0
25
0
RT @robmentz: Whether you're a device guru or someone who can't seem to remember anything about HF devices, this new Scientific Statement f…
0
41
0
RT @AHAScience: 🆕statement on evaluating & managing kidney dysfunction in patients with advanced heart failure. 📷Approach to assessment of…
0
20
0
RT @BiykemB: 🔥🔥🔥 An essential resource! Outstanding review on steroidal versus nonsteroidal MRA in HF. All trials, mechanisms, profiles.…
0
103
0
RT @BiykemB: Gender & Race Differences in HeartMate3 LVAD as a Bridge to Transplantation @JACCJournals #JACCHF Bl…
0
15
0
RT @BiykemB: The DOAC LVAD (Evaluation of the Hemocompatibility of the DOAC Apixaban vs Warfarin in LVAD) Phase II RCT out! DOAC was safe w…
0
36
0
RT @JBauersachsMD: 🔥Hot of the press as simultaneous publication in #EHJ‼️ ➡️Bromocriptine and outcomes in peripartum cardiomyopathy: the E…
0
12
0
RT @NEJM: RESHAPE-HF trial: Among patients with at least moderate functional mitral regurgitation, transcatheter valve repair led to a lowe…
0
111
0
RT @brendonneuen: GLP-1 RA reduces CV events & CKD progression, independent of SGLT2i - supporting combination therapy with both agents to…
0
94
0
RT @JAMA_current: From @JAMACardio: In this pooled analysis of PARADIGM-HF/PARAGON-HF RCTs, sacubitril/valsartan significantly reduced all-…
0
8
0
RT @JACCJournals: New analysis from CANVAS and CREDENCE trials reveals a bidirectional relationship between CV events and #CKD progression…
0
19
0